Enterococcus faecalis 2001, a probiotic lactic acid bacterium can inhibit the growth of tumors, reveals a new study.
The research team has used Enterococcus faecalis 2001 as a biological response modifier (BRM).
How to Detect Circulating Tumor Cells
A researcher at Gold Coast's Bond University suggests that opting for a psychological acupuncture could help reduce food cravings and lose weight.
Advertisement
‘Enterococcus faecalis 2001 can enhance antioxidative activity, improves immune response and completely suppresses the growth of Sarcoma-180 cells.’
Tweet it Now
From physiological limitation of bacterial preservation in storage and safety, the live E. faecalis 2001 has been heat-treated and the BRM components containing high level of £]-glucan, named EF-2001, were prepared.
The heat-treated EF-2001 has been examined for the antioxidative potential for radical scavenging and anti-tumor activities as well as immune-enhancing response in mice.
![Self-perpetuating Signaling Circuit can Drive Tumor Cells to Spread]( "Self-perpetuating Signaling Circuit can Drive Tumor Cells to Spread")
International researchers has identified a self-perpetuating signaling circuit inside connective tissue cells that allows these cells to form a front and a back and propelthemselves in a particular direction over a long period of time.
Lymphocyte versus polymorphonuclear leukocyte ratio was increased in mice upon treatment with EF-2001. The number of lymphocytes was increased in the EF-2001-treated group.
In the mice bearing two different Ehrlich solid and Sarcoma-180 carcinomas, the treatment with EF-2001 resulted in anti-tumor action.
Tumor-suppressive capacity upon treatment with EF-2001 was significantly increased compared to normal controls.
During the time interval administration of 5 weeks between the priming and secondary administration of EF-2001, the expression and production levels of TNF-£\ were also observed in the EF-2001 administered mice.
Additionally, anti-tumor activity examined with the intravenous administration of EF 2001 with a 34 time intervals was also observed, as the growth of Sarcoma-180 cells was clearly inhibited by the EF-2001.
From the results, it was suggested that the immune response is enhanced due to antioxidative activity caused by the EF-2001 and anti-tumor activity by NK cells and TNF-£\.
Source: Eurekalert
Self-perpetuating Signaling Circuit can Drive Tumor Cells to Spread
International researchers has identified a self-perpetuating signaling circuit inside connective tissue cells that allows these cells to form a front and a back and propelthemselves in a particular direction over a long period of time.
Advertisement
Lymphocyte versus polymorphonuclear leukocyte ratio was increased in mice upon treatment with EF-2001. The number of lymphocytes was increased in the EF-2001-treated group.
In the mice bearing two different Ehrlich solid and Sarcoma-180 carcinomas, the treatment with EF-2001 resulted in anti-tumor action.
Tumor-suppressive capacity upon treatment with EF-2001 was significantly increased compared to normal controls.
During the time interval administration of 5 weeks between the priming and secondary administration of EF-2001, the expression and production levels of TNF-£\ were also observed in the EF-2001 administered mice.
Additionally, anti-tumor activity examined with the intravenous administration of EF 2001 with a 34 time intervals was also observed, as the growth of Sarcoma-180 cells was clearly inhibited by the EF-2001.
From the results, it was suggested that the immune response is enhanced due to antioxidative activity caused by the EF-2001 and anti-tumor activity by NK cells and TNF-£\.
Source: Eurekalert
Tumor Cells Influence Their Environment in Order to Avoid an Immune Response
The immune system becomes suppressed when the degenerated cells cause an inflammatory reaction and influence other blood cells with it.
Advertisement
 Protein Helps Tumor Cells Enter the BloodstreamGenerally cancer cells have something that every prisoner longs for, that is a master key that allows them to escape. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.
Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.
Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.